• Profile

Two‐year safety and efficacy outcomes for the treatment of overactive bladder using a long‐lived rechargeable sacral neuromodulation system

Neurourology and Urodynamics Apr 08, 2020

Blok B, Van Kerrebroeck P, de Wachter S, et al. - Since the Axonics System is the first rechargeable sacral neuromodulation (SNM) device and is qualified to last a minimum of 15 years in the body. The study was undertaken to investigate the safety and efficacy of this rechargeable SNM system. A total of 51 subjectssum of 51 individuals were implanted with the Axonics System in a single nonstaged technique. It was noted that 90% of the Test Responders continued to respond to the therapy based on voiding diary criteria at 2 years. At 2 years, clinically meaningful improvements were found after using the Axonics System® in overactive bladder (OAB) individuals. No serious device‐related AEs were noted. Continued satisfaction was reported in the individuals with the therapy.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free.
  • 55 lakhs+ doctors trust M3 globally

  • Nonloggedininfinity icon
    Unlimited access to original articles by experts
  • Nonloggedinlock icon
    Secure: we never sell your data
  • Signing up takes less than 2 mins
Try M3 India / Log In
M3 app logo
Choose easy access to M3 India from your mobile!

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen